Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × Brentuximab Vedotin × Clear all

Sponsor

Conditions

Hodgkin Disease 24 Lymphoma 14 Lymphoma, Large-Cell, Anaplastic 12 Hematologic Diseases 10 Recurrence 8 Lymphoma, T-Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphatic Diseases 3 Leukemia 3 Neoplasms, Germ Cell and Embryonal 2 Neoplasms by Histologic Type 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoproliferative Disorders 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia, Myeloid, Acute 2 Immunoproliferative Disorders 2 Immunoblastic Lymphadenopathy 2 Immune System Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Testicular Neoplasms 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nonseminomatous germ cell tumor 1 Myelodysplastic Syndromes 1 Mastocytosis, Systemic 1

Interventions

Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Valganciclovir 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡